SCHEMBL7605727

SCHEMBL7605727

CCCOCn1c(=O)c2c(ncn2Cc2ccccc2)n(CC)c1=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.55
ALDH1A1 P00352 3/20 0.55
POLB P06746 1/20 0.54
HIF1A Q16665 1/20 0.54
MEN1 O00255 4/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ADORA2B P29275 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
CNOT7 Q9UIV1 2/20 0.52
PDE1A P54750 1/20 0.52
PDE1B Q01064 1/20 0.52
PDE1C Q14123 1/20 0.52
HPGD P15428 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
KDM4E B2RXH2 1/20 0.49
USP2 O75604 1/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7606356 0.90 PDE1A (0.67) KMT2AALDH1A1POLBHIF1AMEN1
SCHEMBL7608741 0.88 POLB (0.53) KMT2AALDH1A1POLBHIF1AMEN1
SCHEMBL7607915 0.88 ALDH1A1 (0.50) KMT2AALDH1A1POLBHIF1AMEN1
SCHEMBL555093 0.87 ALDH1A1 (0.65) KMT2AALDH1A1POLBHIF1AMEN1
SCHEMBL7606543 0.86 POLB (0.57) KMT2AALDH1A1POLBHIF1AMEN1
SCHEMBL7608527 0.85 POLB (0.59) KMT2AALDH1A1POLBHIF1AMEN1
SCHEMBL7604330 0.83 PDE1A (0.55) KMT2AALDH1A1POLBHIF1AMEN1
SCHEMBL7603086 0.82 KMT2A (0.62) KMT2AALDH1A1POLBHIF1AMEN1
SCHEMBL3186736 0.82 CNOT7 (0.61) KMT2AALDH1A1POLBHIF1AMEN1
SCHEMBL1944712 0.81 POLB (0.70) KMT2AALDH1A1POLBHIF1AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 EP disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 US disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed